Skip to the page

Data / Drug companies / Direct RX

Direct RX: 81 products in the FDA NDC directory, labeler code 61919

Direct RX (labeler code 61919) lists 81 products in the FDA National Drug Code Directory, covering 60 finished drugs by generic name. By type: 81 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on March 16, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
61919
Products in commercial distribution
81
Packages
179
Finished drugs by generic name
60
Prescription products
81
Over the counter products
0
Controlled substance products
Schedule II 1, Schedule III 2, Schedule IV 9
Started marketing in the last 12 months
1
Products with a marketing end date set
1
Earliest marketing start
January 1, 2014
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)7896.3%
New drug applications (NDA)22.5%
Authorized generics (NDA)11.2%

Products by type

TypeProductsShare
Prescription drugs81100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Tablet3138.3%
Capsule2024.7%
Tablet, film coated911.1%
Tablet, extended release56.2%
Cream44.9%
Ointment33.7%
Solution/ drops22.5%
Tablet, delayed release11.2%
Patch11.2%
Tablet, film coated, extended release11.2%
Tablet, orally disintegrating11.2%
Powder, for suspension11.2%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Triamcinolone Acetonide61919-234CreamGeneric drugs (ANDA)March 16, 2026
Topiramate61919-213TabletGeneric drugs (ANDA)April 17, 2024
Bupropion HCL ER (XL)61919-558Tablet, extended releaseGeneric drugs (ANDA)February 15, 2024
Nitrofurantoin Macrocrystals61919-842CapsuleGeneric drugs (ANDA)February 7, 2024
Mirtazapine61919-153Tablet, film coatedGeneric drugs (ANDA)May 10, 2022
Divalproex sodium61919-249Tablet, delayed releaseGeneric drugs (ANDA)April 6, 2022
Furosemide61919-255TabletGeneric drugs (ANDA)October 21, 2021
Nortriptyline hydrochloride61919-353CapsuleGeneric drugs (ANDA)September 15, 2021
Triamcinolone acetonide61919-619OintmentGeneric drugs (ANDA)February 4, 2021
Metoprolol succinate61919-334Tablet, extended releaseGeneric drugs (ANDA)January 19, 2021
Furosemide61919-242TabletGeneric drugs (ANDA)June 18, 2020
Dexamethasone61919-827TabletGeneric drugs (ANDA)June 15, 2020
Lidocaine61919-588PatchAuthorized generics (NDA)May 12, 2020
Metaxalone61919-832TabletGeneric drugs (ANDA)January 6, 2020
Diazepam61919-409TabletGeneric drugs (ANDA)November 18, 2019
Metaxalone61919-832TabletGeneric drugs (ANDA)August 29, 2019
Ondansetron61919-565Tablet, film coatedGeneric drugs (ANDA)August 22, 2019
Ibuprofen61919-463Tablet, film coatedGeneric drugs (ANDA)August 22, 2019
Oxycodone and acetaminophen61919-871TabletGeneric drugs (ANDA)August 21, 2019
Metronidazole61919-032Tablet, film coatedGeneric drugs (ANDA)August 21, 2019
Zolpidem tartrate61919-751TabletGeneric drugs (ANDA)August 19, 2019
Cyclobenzaprine hydrochloride61919-261Tablet, film coatedGeneric drugs (ANDA)August 16, 2019
Cephalexin61919-606CapsuleGeneric drugs (ANDA)August 14, 2019
Tizandine61919-811TabletGeneric drugs (ANDA)August 13, 2019
Sulfameth/Trimeth-DS61919-645TabletGeneric drugs (ANDA)August 13, 2019

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.